5 January 2018 — Climate&Capitalism
Readers’ choices
The 109 articles we published in Climate & Capitalism in 2017 were read by more people than ever before. These were the most popular …
Continue reading
5 January 2018 — Climate&Capitalism
The 109 articles we published in Climate & Capitalism in 2017 were read by more people than ever before. These were the most popular …
Continue reading
5 January 2018 — FAIR
Since the outbreak of mass demonstrations and unrest in Iran last week, US media have mostly busied themselves with the question of not if we should “do something,” but what, exactly, that something should be. As usual, it’s simply taken for granted the United States has a divine right to intervene in the affairs of Iran, under the vague blanket of “human rights” and “democracy promotion.” (The rare exception, such as an op-ed by ex-Obama official Philip Gordon—New York Times, 12/30/17—still accepted the premise of regime change: “I, too, want to see the government in Tehran weakened, moderated or even removed.”) With this axiom firmly established in Very Serious foreign policy circles, the next question becomes the nature, degree and scope of the “something” being done.
4 January 2018 — 38 Degrees
Giant corporations suing our government. Restricted access to medicines we all need. That’s what the government is considering in a trade deal right now. [1]
Trade minister Liam Fox is exploring whether the UK should join a dodgy trade deal called the Trans-Pacific Partnership, or TPP for short. It could mean our healthcare, our food standards and our rights at work put at risk. [2]